Kiran Mazumber Shaw
- All
- News
-
Infosys Announces Retirement of Kiran Mazumdar-Shaw as Independent Director: All Details
- Thursday March 23, 2023
- ANI
Infosys announced on Thursday that Kiran Mazumdar-Shaw has retired as Independent Director from the company's board as of March 22. The company said it has now appointed D Sundaram, who has been on the board since 2017, as Lead Independent Director of Infosys.
- www.gadgets360.com
-
Biocon Chief Says Husband's Trust Wrongly Implicated In Pandora Papers Leak
- Monday October 4, 2021
- Business | Press Trust of India
Kiran Mazumdar-Shaw on Monday said media reports on the ''Pandora Papers'' leak have wrongly implicated her husband's offshore trust
- www.ndtv.com/business
-
Biocon Gains After Arm Enters Strategic Alliance With Serum Institute
- Friday September 17, 2021
- Business | Edited by Abhishek Vasudev
Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.
- www.ndtv.com/business
-
"Focus On Creating Digital Economy": Kiran Mazumdar-Shaw To Congress
- Monday January 21, 2019
- India News | Press Trust of India
India's biotechnology industry pioneer Kiran Mazumdar-Shaw urged the Congress to commit itself to the growth of a robust digital economy in the country and include it in its 2019 Lok Sabha poll manifesto.
- www.ndtv.com
-
Infosys Announces Retirement of Kiran Mazumdar-Shaw as Independent Director: All Details
- Thursday March 23, 2023
- ANI
Infosys announced on Thursday that Kiran Mazumdar-Shaw has retired as Independent Director from the company's board as of March 22. The company said it has now appointed D Sundaram, who has been on the board since 2017, as Lead Independent Director of Infosys.
- www.gadgets360.com
-
Biocon Chief Says Husband's Trust Wrongly Implicated In Pandora Papers Leak
- Monday October 4, 2021
- Business | Press Trust of India
Kiran Mazumdar-Shaw on Monday said media reports on the ''Pandora Papers'' leak have wrongly implicated her husband's offshore trust
- www.ndtv.com/business
-
Biocon Gains After Arm Enters Strategic Alliance With Serum Institute
- Friday September 17, 2021
- Business | Edited by Abhishek Vasudev
Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.
- www.ndtv.com/business
-
"Focus On Creating Digital Economy": Kiran Mazumdar-Shaw To Congress
- Monday January 21, 2019
- India News | Press Trust of India
India's biotechnology industry pioneer Kiran Mazumdar-Shaw urged the Congress to commit itself to the growth of a robust digital economy in the country and include it in its 2019 Lok Sabha poll manifesto.
- www.ndtv.com